Metric Finance
LearnFAQ
LearnFAQ

Learn / GHRS

NASDAQ: GHRS

GH Research PLC (GHRS) stock, explained like you're 5

GH Research PLC trades on the Nasdaq under the ticker GHRS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.

Ticker
GHRS
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.4 billion dollars

Is GH Research PLC a small, medium or large cap company?

No. GH Research PLC is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.4 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How GH Research PLC makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves GHRS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • GHRS Apr 2027 17.500 call (GHRS270416C00017500) Stock Historical Prices & Data (Yahoo! Finance Canada)
  • Three trial posters from GH Research (GHRS) are scheduled for October 11, 2026, in Munich. (Stock Titan)
  • GH Research (GHRS) Stock Looks Stretched On Its 111% YTD Run (Simply Wall Street)
  • Trading Systems Reacting to (GHRS) Volatility (Stock Traders Daily)
  • CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners (TradingView)

Follow GHRS in your daily brief

Each trading day at 5 PM ET we post what happened to GH Research PLC and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow GHRS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about GH Research PLC stock

What does GH Research PLC do?

GH Research PLC trades on the Nasdaq under the ticker GHRS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.

What is the ticker symbol for GH Research PLC?

GH Research PLC trades under the ticker GHRS on the Nasdaq.

What is GH Research PLC's market cap?

GH Research PLC is a small cap stock with a market cap of about 1.4 billion dollars.

How does GH Research PLC make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves GHRS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow GHRS stock every day?

Add GHRS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow GHRS daily

A free brief on GH Research PLC and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare GHRS: GHRS vs NVS, GHRS vs AZN, GHRS vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed